← 返回

叉头框 P3 T 调节淋巴细胞在恶性黑色素瘤中的表达及其作为预后因素的研究

英文原题:The Expression of Forkhead Box P3 T Regulatory Lymphocytes as a Prognostic Factor in Malignant Melanomas.

查看英文原题

The Expression of Forkhead Box P3 T Regulatory Lymphocytes as a Prognostic Factor in Malignant Melanomas.

PubMed 2024/06/09(内容时间) Int J Mol Sci Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

由于转录因子Forkhead Box P3(FoxP3)被确定为特异性调节性T细胞(Treg)标志物,研究人员已对其作为潜在新型治疗靶点或多种癌症预后因素的价值进行了深入探究,但结果并不一致。本分析旨在评估Treg FoxP3表达对原发性黑色素瘤预后的影响,并评估其与各种临床病理预后因素的相关性。

我们分析了在一家三级癌症中心接受治疗的所有符合条件的pT3期原发性恶性黑色素瘤患者。对回顾性鉴定的石蜡块进行Treg FoxP3表达的免疫组化染色,随后与患者结局进行相关性分析。共有81%的患者呈现Treg FoxP3阳性表达,与淋巴结转移、肿瘤复发和死亡风险较高相关。

此外,阳性表达与较短的OS在统计学上相关。肿瘤复发率估计为36.7%。基于多因素分析,Treg FoxP3阳性表达和淋巴结转移与较高的死亡风险相关。Treg FoxP3表达可作为恶性黑色素瘤患者的独立预后因素,用于评估肿瘤进展和生存。

展开英文摘要原文

Since transcription factor Forkhead Box P3 (FoxP3) was identified as a specific regulatory T cell (Treg) marker, researchers have scrutinized its value as a potential novel therapeutic target or a prognostic factor in various types of cancer with inconsistent results. The present analysis was performed to assess the influence of Treg FoxP3 expression on the prognosis of primary melanoma and to evaluate the correlations with various clinicopathological prognostic factors.

We analyzed all eligible patients with stage pT3 primary malignant melanomas treated in a tertiary cancer center. Immunohistochemical staining for Treg FoxP3 expression was performed on retrospectively identified paraffin blocks and subsequently correlated with the outcomes of the patients. A total of 81% of the patients presented a positive Treg FoxP3 expression, being correlated with a higher risk of lymph node metastasis, tumor relapse, and death.

Moreover, positive expression was statistically associated with a shorter OS. The tumor relapse rate was estimated at 36. 7%. A positive expression of Treg FoxP3 and lymph node metastasis were associated with a higher risk of death based on multivariate analysis. Treg FoxP3 expression may be used as an independent prognostic factor in patients with malignant melanoma to evaluate tumor progression and survival.

论文信息

作者
Gâta VA、Pașca A、Roman A、Muntean MV、Morariu DȘ、Bonci EA、Dina C、Ungureanu L
第一作者单位
Department of Surgical Oncology and Gynecologic Oncology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.Italy
通讯作者单位
Department of Dermatology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.Italy
期刊
International journal of molecular sciences2024 Jun 9
原文标识
PubMed 38928083 · DOI 10.3390/ijms25126377